GR1000965B - Παραγωγα της σακχαρινης χρησιμοποιουμενα ως ανασταλτικα των πρωτεολυτικων ενζυμων και μεθοδος παρασκευης αυτων - Google Patents

Παραγωγα της σακχαρινης χρησιμοποιουμενα ως ανασταλτικα των πρωτεολυτικων ενζυμων και μεθοδος παρασκευης αυτων

Info

Publication number
GR1000965B
GR1000965B GR900100326A GR900100326A GR1000965B GR 1000965 B GR1000965 B GR 1000965B GR 900100326 A GR900100326 A GR 900100326A GR 900100326 A GR900100326 A GR 900100326A GR 1000965 B GR1000965 B GR 1000965B
Authority
GR
Greece
Prior art keywords
proteolytic enzyme
enzyme inhibitors
preparation
derivatives useful
saccharin derivatives
Prior art date
Application number
GR900100326A
Other languages
English (en)
Other versions
GR900100326A (en
Inventor
Warren Neil Boaz
Paul Richard Dunlap
John Dennis Hlasta
Joseph Albert Mura
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of GR900100326A publication Critical patent/GR900100326A/el
Publication of GR1000965B publication Critical patent/GR1000965B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

Νέα 2-υποκατεστημένα παράγωγα της σακχαρίνης χρήσιμα δια την αναστολή της δραστικότητας πρωτεολυτικών ενζύμων, συνθέσεις περιέχουσες αυτά δια την θεραπεία εκφυλιστικών παθήσεων και μέθοδος χρησιμοποιήσεώς των. ω
GR900100326A 1989-05-04 1990-05-02 Παραγωγα της σακχαρινης χρησιμοποιουμενα ως ανασταλτικα των πρωτεολυτικων ενζυμων και μεθοδος παρασκευης αυτων GR1000965B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34712589A 1989-05-04 1989-05-04
US34712689A 1989-05-04 1989-05-04

Publications (2)

Publication Number Publication Date
GR900100326A GR900100326A (en) 1991-10-10
GR1000965B true GR1000965B (el) 1993-03-16

Family

ID=26995139

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100326A GR1000965B (el) 1989-05-04 1990-05-02 Παραγωγα της σακχαρινης χρησιμοποιουμενα ως ανασταλτικα των πρωτεολυτικων ενζυμων και μεθοδος παρασκευης αυτων

Country Status (17)

Country Link
EP (1) EP0471756B1 (el)
JP (1) JPH04507095A (el)
KR (1) KR0183397B1 (el)
AT (1) ATE159720T1 (el)
AU (1) AU637614B2 (el)
DE (1) DE69031656T2 (el)
DK (1) DK0471756T3 (el)
ES (1) ES2110414T3 (el)
FI (1) FI103111B1 (el)
GR (1) GR1000965B (el)
IL (1) IL94278A (el)
MY (1) MY106202A (el)
NO (1) NO300808B1 (el)
NZ (1) NZ233521A (el)
PT (1) PT93959B (el)
SG (1) SG48298A1 (el)
WO (1) WO1990013549A1 (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW282463B (el) * 1991-11-15 1996-08-01 Sterling Winthrop Inc
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (el) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
DE4413951C1 (de) * 1994-04-21 1995-08-03 Cpc Maizena Gmbh Verfahren zur Herstellung einer Würzsoße
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
US5494925A (en) * 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
EP2203412A4 (en) * 2007-10-16 2012-01-11 Univ Northeastern MONOACYLGLYCEROLLIPASE HEMMER FOR MODULATION OF CANNABINOIDACTIVITY

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302858B (el) * 1962-09-21 1972-05-04
JPS47419B1 (el) * 1969-12-22 1972-01-07
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
DE2800019A1 (de) * 1978-01-02 1979-07-12 Dynamit Nobel Ag N-halobenzyl-saccharine, ihre herstellung und verwendung
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
CS241932B1 (cs) * 1984-05-25 1986-04-17 Jiri Svoboda Způsob výroby substituovaných benzisothiazolin- -3-on-l,1-dioxidů
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置

Also Published As

Publication number Publication date
NO914217L (no) 1991-10-28
JPH04507095A (ja) 1992-12-10
NO914217D0 (no) 1991-10-28
FI103111B (fi) 1999-04-30
AU637614B2 (en) 1993-06-03
PT93959A (pt) 1991-01-08
KR920701203A (ko) 1992-08-11
ATE159720T1 (de) 1997-11-15
KR0183397B1 (ko) 1999-05-01
PT93959B (pt) 1996-11-29
NZ233521A (en) 1992-05-26
DE69031656T2 (de) 1998-04-09
MY106202A (en) 1995-03-31
EP0471756A4 (en) 1992-04-08
WO1990013549A1 (en) 1990-11-15
ES2110414T3 (es) 1998-02-16
GR900100326A (en) 1991-10-10
FI103111B1 (fi) 1999-04-30
NO300808B1 (no) 1997-07-28
DK0471756T3 (da) 1998-05-18
IL94278A (en) 1995-03-30
DE69031656D1 (de) 1997-12-04
SG48298A1 (en) 1998-04-17
FI915093A0 (fi) 1991-10-29
EP0471756B1 (en) 1997-10-29
IL94278A0 (en) 1991-03-10
EP0471756A1 (en) 1992-02-26
AU5664990A (en) 1990-11-29

Similar Documents

Publication Publication Date Title
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL81887A0 (en) Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
FI103114B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi